SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

UPDATE: PiperJaffray Reiterates Overweight On Bausch Health Companies, Raises Target To $39 Based On Firm's Read Of Key Segments Of The Business '(e.g., dermatology; gastroenterology, namely Xifaxan and Trulance)'

Benzinga · 12/30/2019 15:28